DC Chemicals · Product datasheet

BL-AD008 · DC12391

BL-AD008 is an AMPK/ZIPK-directed activator investigated in cervical-cancer apoptosis research.

ParameterValue
Chemical Name(Z)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-3-benzylidene-6-chloroindolin-2-one
CAS No.Not available
SynonymsBL-AD008; BL-AD 008
FormulaC28H25ClN4OS
M.Wt501.045
SMILESN1C2=C(C=C(CCN3CCN(C4C5=CC=CC=C5SN=4)CC3)C(Cl)=C2)/C(=C/C2=CC=CC=C2)/C1=O
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity summary

BL-AD008 is an AMPK/ZIPK-directed activator investigated in cervical-cancer apoptosis research.

View referenced In Vitro and In Vivo results on the product page

References

  1. Fu L, et al. Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer. Oncotarget (2015).

Available packs

  • 10mg · US$550
  • 25 mg · US$900
View product and biological activity →

Cart

Request quotation